Latest Regulatory Filings News

Astron Limited has responded to an ASX query regarding delayed disclosure of director interest changes, attributing the lapse to administrative oversight and outlining steps to tighten compliance.

Finder Energy has completed a $5.2 million capital raise through a share placement to its directors and substantial shareholder Longreach Capital, following shareholder approval.

APC Minerals Limited has successfully closed its pro-rata renounceable entitlement offer, raising $1.38 million despite strong investor demand that exceeded the offer size by over 50%.

Eastern Metals Limited has responded to ASX concerns over delayed disclosure of director interest changes, attributing the lapse to end-of-year administrative challenges while affirming its compliance framework remains robust.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Racura Oncology has launched a strategic collaboration with Emory University to investigate (E,E)-bisantrene’s potential to overcome resistance to osimertinib in EGFR-mutated non-small cell lung cancer. This partnership aims to bolster Racura’s HARNESS-1 clinical trial and strengthen its position in the competitive lung cancer treatment landscape.

NeuroScientific Biopharmaceuticals reports encouraging clinical responses in fistulising Crohn’s disease patients treated under Australia’s Special Access Scheme, setting the stage for pivotal Phase 2 trials later this year.

StepChange Holdings has completed its acquisition of Perth-based ICT advisory firm BroadReach, significantly boosting its digital transformation and government consulting capabilities.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its Vision-MR Diagnostic Catheter, paving the way for commercial sales in the US electrophysiology market.

Ryzon Materials Limited faces ASX scrutiny over the timing and disclosure of a $1 million advance from Xinhai Mining, with the company responding to regulatory queries and committing to improved governance.

RocketBoots Limited has responded to ASX concerns over a delayed director interest disclosure, attributing the lapse to an administrative oversight during a holdings restructure. The company affirms its compliance policies and has taken steps to prevent future delays.